A Study of AP601 in Patients With Locally Unresectable Advanced or Metastatic Solid Tumors
Clinical trial NCT07165067 · RECRUITING
Trial details
- NCT number
- NCT07165067
- Sponsor
- AP Biosciences Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-21
- Primary completion
- 2027-12-27
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.